Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin

被引:0
|
作者
A. Ephrem
N. Misra
G. Hassan
S. Dasgupta
S. Delignat
J.-P. Duong Van Huyen
S. Chamat
F. Prost
S. Lacroix-Desmazes
S. V. Kavery
M. D Kazatchkine
机构
[1] INSERM U430 and Université Pierre et Marie Curie (UPMC-Paris 6),
[2] Hôpital Broussais,undefined
来源
关键词
Intravenous immunoglobulin; Autoimmune disorders; Inflammatory diseases; Mechanisms;
D O I
暂无
中图分类号
学科分类号
摘要
Intravenous immunoglobulin (IVIg) has been used in the treatment of primary and secondary antibody deficiencies for over two decades. Since the early 1980s, the therapeutic efficacy of IVIg has been established in idiopathic thrombocytopenic purpura, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, dermatomyositis and Kawasaki syndrome, and the prevention of graft versus host disease in recipients of allogeneic bone marrow transplants. Its use has also been reported in a large number of other autoimmune and systemic inflammatory conditions. In this review, we discuss the mechanisms by which IVIg exerts immunomodulatory effects in immune pathologies.
引用
收藏
页码:135 / 140
页数:5
相关论文
共 50 条
  • [1] Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin
    Ephrem, A
    Misra, N
    Hassan, G
    Dasgupta, S
    Delignat, S
    Van Huyen, JP
    Chamat, S
    Prost, F
    Lacroix-Desmazes, S
    Kavery, SV
    Kazatchkine, MD
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2005, 5 (04) : 135 - 140
  • [2] IMMUNOMODULATION OF AUTOIMMUNE AND SYSTEMIC INFLAMMATORY DISEASES WITH INTRAVENOUS IMMUNOGLOBULIN
    MOUTHON, L
    PIKETTY, C
    KAZATCHKINE, MD
    [J]. VOX SANGUINIS, 1994, 67 : 53 - 59
  • [3] Immunomodulation of various autoimmune diseases by intravenous immunoglobulin
    Sherer, Y
    Levy, Y
    Fabrizzi, F
    Shoenfeld, Y
    [J]. DRUGS OF TODAY, 1999, 35 (07): : 513 - 518
  • [4] Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
    Bayry, J
    Thirion, M
    Misra, N
    Thorenoor, N
    Delignat, S
    Lacroix-Desmazes, S
    Bellon, B
    Kaveri, S
    Kazatchkine, MD
    [J]. NEUROLOGICAL SCIENCES, 2003, 24 (Suppl 4) : S217 - S221
  • [5] INTRAVENOUS IMMUNOGLOBULIN THERAPY OF AUTOIMMUNE AND SYSTEMIC INFLAMMATORY DISEASES
    RONDA, N
    HUREZ, V
    KAZATCHKINE, MD
    [J]. VOX SANGUINIS, 1993, 64 (02) : 65 - 72
  • [6] Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
    Kazatchkine, MD
    Bayry, J
    Lacroix-Desmazes, S
    Kaveri, SV
    [J]. INTRAVENOUS IMMUNOGLOBULINS IN THE THIRD MILLENNIUM, 2004, : 105 - 111
  • [7] IMMUNOMODULATING EFFECTS OF INTRAVENOUS IMMUNOGLOBULIN IN AUTOIMMUNE AND INFLAMMATORY DISEASES
    KAVERI, SV
    MOUTHON, L
    KAZATCHKINE, MD
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 : 6 - 8
  • [8] INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
    DESOUZA, VR
    KAVERI, SV
    KAZATCHKINE, MD
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1993, 11 : S33 - S36
  • [9] Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
    J. Bayry
    M. Thirion
    N. Misra
    N. Thorenoor
    S. Delignat
    S. Lacroix-Desmazes
    B. Bellon
    S. Kaveri
    M. D. Kazatchkine
    [J]. Neurological Sciences, 2003, 24 : s217 - s221
  • [10] Advances in immunology: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
    Kazatchkine, MD
    Kaveri, SV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (10): : 747 - 755